share_log

Sarepta Therapeutics Price Target Raised to $126.00/Share From $125.00 by SVB Leerink

Dow Jones Newswires ·  Mar 2, 2021 20:19

DJ Sarepta Therapeutics Is Maintained at Outperform by SVB Leerink

Ratings actions from Benzinga: https://www.benzinga.com/stock/SRPT/ratings

(END) Dow Jones Newswires

March 02, 2021 07:19 ET (12:19 GMT)

DJ Sarepta Therapeutics Price Target Raised to $126.00/Share From $125.00 by SVB Leerink

Ratings actions from Benzinga: https://www.benzinga.com/stock/SRPT/ratings

(END) Dow Jones Newswires

March 02, 2021 07:19 ET (12:19 GMT)

The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.
    Write a comment